S'abonner

Long-Term Neurobehavioral and Quality of Life Outcomes of Critically Ill Children after Glycemic Control - 20/02/20

Doi : 10.1016/j.jpeds.2019.10.055 
Katherine V. Biagas, MD 1, , Veronica J. Hinton, PhD 2, Natalie R. Hasbani, MPH 3, Peter M. Luckett, MD 4, David Wypij, MD 3, Vinay M. Nadkarni, MD 5, Michael S.D. Agus, MD 6
on behalf of the

HALF-PINT trial study investigators

  List of the HALF-PINT trial study investigators is available at www.jpeds.com (Appendix).
Vijay Srinivasan, MD, Peter M. Mourani, MD, Ranjit Chima, MD, Neal J. Thomas, MD, MS, Simon Li, MD, MPH, Alan Pinto, MD, Christopher Newth, MD, FRCPC, Amanda Hassinger, MD, MS, Kris Bysani, MD, Kyle J. Rehder, MD, Edward Vincent Faustino, MD, MHS, Sarah Kandil, MD, Eliotte Hirshberg, MD, Kupper Wintergerst, MD, Adam Schwarz, MD, Dayanand Bagdure, MD, Lauren Marsillio, MD, Natalie Cvijanovich, MD, Nga Pham, MD, Michael Quasney, MD, Heidi Flori, MD, Myke Federman, MD, Sholeen Nett, MD, Neethi Pinto, MD, MS, Shirley Viteri, MD, James Schneider, MD, Shivanand Medar, MD, Anil Sapru, MD, Patrick McQuillen, MD, Christopher Babbitt, MD, John C. Lin, MD, Philippe Jouvet, MD, Ofer Yanay, MD, Christine Allen, MD, Lisa Asaro, MS, Kerry Coughlin-Wells, RN, MPH, Jaclyn French, Aruna Natarajan, MD, PhD

the PALISI Network

1 Department of Pediatrics, Stony Brook Children's Hospital and the Renaissance School of Medicine, Stony Brook, NY 
2 Department of Psychology, Queens College and the Graduate Center of the City University of New York, New York, NY 
3 Department of Cardiology, Boston Children's Hospital and Harvard Medical School, Boston, MA 
4 Department of Pediatrics, University of Texas Southwestern Medical Center and Children's Health, Dallas, TX 
5 Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia and the University of Pennsylvania, Philadelphia, PA 
6 Division of Medical Critical Care, Department of Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, MA 

Reprint requests: Katherine V. Biagas, MD, Division of Pediatric Critical Care Medicine, 101 Nicolls Rd, HSC T11-040, Stony Brook, NY 11794.Division of Pediatric Critical Care Medicine101 Nicolls RdHSC T11-040Stony BrookNY11794

Abstract

Objectives

To investigate adaptive skills, behavior, and quality health-related quality of life in children from 32 centers enrolling in the Heart And Lung Failure-Pediatric INsulin Titration randomized controlled trial.

Study design

This prospective longitudinal cohort study compared the effect of 2 tight glycemic control ranges (lower target, 80-100 mg/dL vs higher target, 150-180 mg/dL) 1-year neurobehavioral and health-related quality of life outcomes. Subjects had confirmed hyperglycemia and cardiac and/or respiratory failure. Patients aged 2-16 years old enrolled between April 2012 and September 2016 were studied at 1 year after intensive care discharge. The primary outcome, adaptive skills, was assessed using the Vineland Adaptive Behavior Scale. Behavior and health-related quality of life outcomes were assessed as secondary outcomes using the Pediatric Quality of Life and Child Behavior Checklist at baseline and 1-year follow-up. Group differences were evaluated using regression models adjusting for age category, baseline overall performance, and risk of mortality.

Results

Of 369 eligible children, 358 survived after hospital discharge and 214 (60%) completed follow-up. One-year Vineland Adaptive Behavior Scale-II composite scores were not different (mean ± SD, 79.9 ± 25.5 vs 79.4 ± 26.9, lower vs higher target; P = .20). Improvement in Pediatric Quality of Life total health from baseline was greater in the higher target group (adjusted mean difference, 8.2; 95% CI, 1.1-15.3; P = .02).

Conclusions

One-year adaptive behavior in critically ill children with lower vs higher target glycemic control did not differ. The higher target group demonstrated improvement from baseline in overall health. This study affirms the lack of benefit of lower glucose targeting.

Trial registration

ClinicalTrials.gov: NCT01565941.

Le texte complet de cet article est disponible en PDF.

Abbreviations : CBCL, HALF-PINT, HRQoL, PedsQL, PICU, POPC, VABS-II


Plan


 Supported by the National Heart, Lung, and Blood Institute (U01HL107681 [to M.A. and V.N.]) and (U01HL108028 [to D.W.]) and the National Center for Advancing Translational Sciences (UL1TR001873 [to K.B.]), and by endowed chairs (to M.A. and V.N.). The authors declare no conflicts of interests.
 Portions of this study were presented at the Pediatric Academic Societies annual meeting, May 5-8, 2018, Toronto, Canada.


© 2019  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 218

P. 57 - mars 2020 Retour au numéro
Article précédent Article précédent
  • 50 Years Ago in The Journal of Pediatrics : Chromosome Studies in Full Term, Low Birth Weight, Mentally Retarded Patients
  • Jannicke H. Andresen, Ola Didrik Saugstad
| Article suivant Article suivant
  • Three-Variate Longitudinal Patterns of Metabolic Control, Body Mass Index, and Insulin Dose during Puberty in a Type 1 Diabetes Cohort: A Group-Based Multitrajectory Analysis
  • Anke Schwandt, Oliver Kuss, Desiree Dunstheimer, Beate Karges, Thomas Kapellen, Thomas Meissner, Michael Witsch, Monika Flury, Stefanie Straubinger, Reinhard W. Holl, Diabetes-Patienten-Verlaufsdokumentation (DPV) Initiative

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.